Biotech

All Articles

Analysts dig into Avidity's DMD succeed, showing distinctions in data

.Avidity Biosciences pleased capitalists along with phase 1/2 information in Duchenne muscle dystrop...

Actinogen's cortisol blocker falls short phase 2 clinical depression study

.Actinogen Medical's cortisol blocker has skipped the major endpoint of a phase 2 study in anxiety, ...

Bivictrix decides going exclusive only technique to take ADC right into clinic

.Antibody-drug conjugates (ADCs) have gone to the center of a lot of a billion-dollar biobuck licens...

TPG bests up funds to $580M for assets around life sciences

.Resource manager TPG, which has sustained biotechs such as Sionna Therapeutics and Santa Ana Biogra...

Merck ceases period 3 TIGIT trial in lung cancer cells for futility

.Merck &amp Co.'s TIGIT system has experienced an additional drawback. Months after shuttering a per...

After a difficult year, Exscientia folds in to Recursion

.After a year described by pipeline cuts, the variation of its CEO and also unemployments, Exscienti...

Cullinan, after $25M deal, return bispecific to Port

.Cullinan Therapeutics was impressed enough along with Harbour BioMed's bispecific invulnerable reac...

A closer check out Strong Biotech's Intense 15

.In this particular week's episode of "The Top Line," we are actually diving right into Ferocious Bi...

Lilly encounters period 2 breakdown of tau-targeting med

.The confetti is still soaring coming from Eli Lilly's party celebrating the commendation of Alzheim...

Biogen CMO Maha Radhakrishnan joins Sofinnova-- Chutes &amp Ladders

.Accept to today's Chutes &amp Ladders, our roundup of substantial leadership hirings, shootings as ...